Add BrightSurf on Google Email

Science News for May 29, 2015


Genetic biomarker may predict cancer patients' response to immunotherapy drug

Researchers identified a genetic biomarker that can predict which cancer patients will respond to immunotherapy drugs like pembrolizumab. Patients with mismatch repair gene defects showed improved responses to the treatment, offering hope for previously failed patients. Larger studies are needed to assess the potential for clinical use.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateMay 29, 2015

Study: Race influences warfarin dose

A new study reveals that clinical and genetic factors affecting warfarin dose vary by race, highlighting the need for race-specific dosing equations to improve anticoagulation control. The research team found that gene variants may have different effects on dose across racial groups, particularly among African Americans.

The Lancet Diabetes & Endocrinology: 2015 ERA-EDTA Congress media alert

A collaborative meta-analysis found that creatinine-based eGFR and albuminuria improve cardiovascular prediction, particularly for mortality and heart failure. The assessment of albumin-to-creatinine ratio (ACR) outperformed traditional risk factors, suggesting its potential broad implications for cardiovascular risk classification.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateMay 29, 2015

The new digital TV standard in the USA incorporates technology developed at the UPV/EHU

The LDM system developed at UPV/EHU has been selected as the technology for the new digital standard in North America, allowing for simultaneous use of TV channels on the UHF band. This system significantly improves the use of the radioelectric spectrum, enabling services such as Ultra High Definition TV and mobile phone broadcasting.

SourceUniversity of the Basque Country·JournalElectronics Letters·DateMay 29, 2015